BLT SKIN CREAM- benzocaine, lidocaine, tetracaine cream

BLT Skin Cream by

Drug Labeling and Warnings

BLT Skin Cream by is a Otc medication manufactured, distributed, or labeled by M2B Pharma LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DRUG FACTS

Active ingredient

Benzocaine 20%

Purpose

Topical anesthetic

Active ingredient

Lidocaine 4%

Purpose

Topical analgesic

Active ingredient

Tetracaine 1%

Purpose

Topical analgesic

Uses

For temporary relief of pain

Warnings

For external use only

Do not use

• On wounds or damaged, broken or irritated skin
• In large quantities
• At the same time as other topical analgesics or anesthetics
• If you are currently taking medication to control heart rate or rhythm or if you have any type of heart disease
• If you are allergic to PABA, benzocaine, lidocaine, tetracaine or other sulfonamides (sulfa) type drugs
• If you are under the age of 17

When using this product

• Use only as directed. Read and follow all directions and warnings on this label.
• Avoid contact with eyes or mucous membrane
• Do not bandage or cover with any type of clear occlusive dressing
• Do not apply heat (such as heating pad) to area of use

Stop use and ask a doctor if

• If redness or skin irritation is present at application site
• Condition worsens
• Symptoms persist for more than 7 days or clear up and occur again within a few days
• You have any heart conditions

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Adults and children over 17 years of age:

• Apply to affected area of pain no more than 3-4 times per day. Do not cover with any occlusive dressing

Do not use on children 17 years and younger without consulting a doctor.

Other Information

• Store at 20-25 degrees C (68-77 degrees F).
• Store away from heat, sunlight, and excessive heat or humidity

Inactive Ingredients

behentrimonium chloride, caprylic/capric triglyceride, cetearyl alcohol, citric acid, dimethyl isosorbide, ethylhexylglycerin, PEG-150 distearate, phenoxyethanol, polyquaternium-37, water

Questions?

1-877-760-1881

info@bltskincream.com

Principal Display Panel

INGREDIENTS AND APPEARANCE

BLT SKIN CREAM 
benzocaine, lidocaine, tetracaine cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 73341-001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	0.2 g  in 1 g
TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV)	TETRACAINE	0.01 g  in 1 g
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	0.04 g  in 1 g

Inactive Ingredients
Ingredient Name	Strength
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
DIMETHYL ISOSORBIDE (UNII: SA6A6V432S)
POLYQUATERNIUM 37 (200 MPA.S) (UNII: 67C1D6YV24)
BEHENTRIMONIUM CHLORIDE (UNII: X7GNG3S47T)
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
WATER (UNII: 059QF0KO0R)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
PEG-150 DISTEARATE (UNII: 6F36Q0I0AC)
PHENOXYETHANOL (UNII: HIE492ZZ3T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 73341-001-30	30 g in 1 JAR; Type 0: Not a Combination Product	02/04/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part348	02/04/2020

Labeler - M2B Pharma LLC (117182771)